USD 5.40 Billion
Human Growth Hormone Market Size, Share, Growth Analysis, By Product(Long Acting, Others), By Application(Growth Hormone (GH) Deficiency (Adult GH Deficiency, Pediatric GH Deficiency), Turner Syndrome, Idiopathic Short Stature), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2308 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|Tables:
68
|Figures:
75
Human Growth Hormone Market Insights
Global Human Growth Hormone Market size was valued at USD 5.5 billion in 2022 and is poised to grow from USD 6.32 billion in 2023 to USD 16.03 billion by 2031, growing at a CAGR of 12.34% during the forecast period (2024-2031).
The purpose of the HGH market is to address growth hormone deficiency and related disorders. It is primarily used for treating children with growth hormone deficiencies and individuals with certain medical conditions, such as Turner syndrome, Prader-Willi syndrome, and chronic kidney disease. Several driving factors contribute to the growth of the HGH market. One key factor is the increasing prevalence of growth hormone-related disorders, including growth hormone deficiency and genetic conditions.
The rising awareness about the benefits of HGH therapy among patients and healthcare providers further drives market growth. the positive market outlook, several restraining factors and challenges exist. The high cost of HGH therapy is a significant barrier, limiting access for some patients and healthcare systems. Additionally, strict regulations and the requirement for prescription-based administration create barriers to market growth. The HGH market presents significant opportunities. The increasing focus on precision medicine and personalized treatment approaches offers avenues for targeted HGH therapies. Moreover, ongoing research and development activities aim to explore the potential applications of HGH in areas such as regenerative medicine, hormone replacement therapy, and age-related disorders. The market also benefits from technological advancements that enhance drug delivery systems and improve treatment outcomes. The global human growth hormone market serves a critical purpose in addressing growth hormone-related disorders. The market's growth is driven by factors such as rising prevalence of related conditions, advancements in biotechnology, and increased awareness.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Hospital Pharmacy
Fastest Growth
Hospital Pharmacy
Growth Rate
8.2% CAGR
Global Human Growth Hormone Market 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)
To get more reports on the above market click here to Buy The Report
Human Growth Hormone Market Segmental Analysis
Global Human Growth Hormone Market is segmented by Product, Application, Distribution Channel and region. Based on Product, the market is segmented into Long Acting, Others. Based on Application, the market is segmented into Growth Hormone (GH) Deficiency (Adult GH Deficiency, Pediatric GH Deficiency), Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Human Growth Hormone Market Analysis by Distribution Channel
The hospital pharmacy segment accounted for a substantial market share in the global human growth hormone (HGH) market. This significant share can be attributed to the growing awareness about GH deficiency among individuals and the subsequent increase in hospital visits for diagnosis and treatment. A report from the children's hospital of Philadelphia (CHOP) highlighted that the number of prescriptions for growth hormone has risen steadily over the years.
The online pharmacy segment is expected to witness a remarkable compound annual growth rate (CAGR) during the forecast period. This projected growth is primarily driven by the widespread availability and accessibility of online pharmacies, particularly in developed regions like North America and Europe. Additionally, the emerging economies of India and China are experiencing a growing trend of online pharmacies, which is expected to further fuel the segment's growth in the coming years.
Human Growth Hormone Market Analysis by Application
The largest segment in the HGH market is growth hormone (GH) deficiency. GH deficiency occurs when the body fails to produce adequate levels of growth hormone, leading to stunted growth and development. This segment holds a prominent position due to the high prevalence of GH deficiency worldwide and the need for HGH therapy to address this condition. The market for GH deficiency is fueled by the rising awareness, increased diagnosis rates, and the growing demand for effective treatment options. With millions of individuals affected by GH deficiency globally, the segment represents a substantial patient pool driving market growth.
The fastest growing segment in the HGH market is Idiopathic Short Stature. Idiopathic short stature refers to individuals who have a height significantly below the average range without any underlying medical conditions. This segment is witnessing rapid growth due to multiple factors. Firstly, the increased recognition and diagnosis of idiopathic short stature have led to a higher demand for treatment options among individuals seeking to achieve normal height. advancements in medical research and technology have allowed for improved assessment and understanding of short stature, enabling better identification and management of individuals with this condition. The demand for HGH therapy as a treatment option for idiopathic short stature is rapidly increasing.
Global Human Growth Hormone Market Size By Distribution Channel, 2022(%)
To get detailed analysis on other segments, Request For Free Sample Report
Human Growth Hormone Market Regional Insights
North America is expected to hold the largest share in the global human growth hormone (HGH) market due to several factors that contribute to its dominance. These factors include a favorable reimbursement scenario, a well-established healthcare infrastructure, significant government initiatives, and a growing healthcare awareness among the population. The region benefits from increased access to novel drugs, thanks to the presence of key players in the market. Notable U.S.-based companies such as Pfizer, Inc., Eli Lilly and Company, and Genentech, Inc. offer a diverse range of human GH therapies in North America, further supporting the growth of the market in the region.
Asia Pacific is projected to witness a significant compound annual growth rate (CAGR) over the forecast period. Key players in the market are strategically focusing on capturing a major market share in countries with high growth potential, such as Japan and China. These players aim to achieve this through gaining approval and launching novel products in these regions. For instance, in March 2017, Novo Nordisk A/S, a Denmark-based pharmaceutical company, initiated a phase III clinical trial of its HGH somapacitan in Japan. This trial aimed to evaluate the efficacy of the product in treating adult growth hormone deficiency. Such initiatives and investments by key players reflect the growing importance and potential of the Asia Pacific market for HGH.
Global Human Growth Hormone Market Size By Geography, 2022-2030
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Human Growth Hormone Market Dynamics
Human Growth Hormone Market Drivers
Increasing Prevalence of Growth Hormone-related Disorders
- The growing prevalence of growth hormone-related disorders, such as growth hormone deficiency and genetic conditions, continues to drive the demand for HGH therapy. In 2022, the awareness and diagnosis of these disorders increased, leading to a higher number of patients seeking treatment. The European Society for Paediatric Endocrinology (ESPE) reported a rise in the incidence of growth hormone deficiency in children across Europe in 2022. This increased incidence fueled the demand for HGH therapy to address growth hormone-related issues in affected children.
Advancements in Biotechnology and Manufacturing
- Advancements in biotechnology and manufacturing processes have played a crucial role in driving the growth of the HGH market. Improved production techniques, including recombinant DNA technology, have resulted in the availability of high-quality synthetic HGH products. In 2022, a leading pharmaceutical company announced the development of a novel recombinant HGH formulation with improved stability and bioavailability. This advancement in manufacturing technology aims to enhance the effectiveness and convenience of HGH therapy for patients.
Human Growth Hormone Market Restraints
High Cost of HGH Therapy
- The expenses related to HGH treatment can be substantial, making it less accessible to certain patient populations and healthcare systems. In 2022, a study published in a medical journal highlighted the financial burden faced by patients and healthcare systems due to the high cost of HGH therapy. This finding emphasized the need for cost-effective solutions and potential pricing reforms to ensure broader access to HGH treatment.
Regulatory Constraints and Prescription Requirements
- Regulatory constraints and the requirement for prescription-based administration pose challenges for the HGH market. Strict regulations govern the distribution and use of HGH products, making it essential for patients to obtain a prescription from a qualified healthcare professional. In 2022, a regulatory agency issued guidelines emphasizing the importance of appropriate prescribing practices for HGH therapy. These guidelines aimed to ensure the safe and responsible use of HGH, highlighting the need for adherence to regulatory requirements.
Request Free Customization of this report to help us to meet your business objectives.
Human Growth Hormone Market Competitive Landscape
The global human growth hormone market is characterized by the presence of several key players striving to gain a significant market share. These companies focus on research and development, strategic partnerships, product launches, and mergers and acquisitions to strengthen their position in the market. companies are actively involved in the production, distribution, and marketing of HGH products, further intensifying the competition in the market. The global HGH market is highly competitive, with several key players striving for market dominance. These companies leverage their research and development capabilities, global presence, and strategic partnerships to gain a competitive edge. As the demand for HGH therapies continues to grow, competition among these players is expected to further intensify, leading to advancements in products, technologies, and treatment approaches to cater to the diverse needs of patients worldwide.
Top Player’s Company Profiles in Human Growth Hormone Market
- Novo Nordisk A/S
- Pfizer, Inc
- Eli Lilly and Company
- Sandoz International GmbH (Novartis AG)
- Merck KGaA
- Genentech , Inc (Roche)
- Ferring Pharmaceuticals
- Teva Pharmaceutical Industries, Ltd
- Ipsen
- GeneScience Pharmaceuticals
- LG Chem
- Anhui Anke Biotechnology Group
- Biopartners
- Endo International
- Versartis
- Opko Health
- Rani Therapeutics
- Somatopac
- Hua'an Biological
- Hangzhou Just Biotech
- Shenzhen Hybio Pharmaceutical
Human Growth Hormone Market Recent Developments
- In April 2022, Novo Nordisk announced positive results from a phase III clinical trial of somapacitan, its long-acting HGH therapy, for the treatment of pediatric patients with growth hormone deficiency.
- In March 2022, Genentech received approval from the U.S. Food and Drug Administration (FDA) for a new indication of its HGH therapy, Nutropin AQ, for the treatment of children with short stature associated with Noonan syndrome.
- In December 2021, Pfizer and OPKO Health entered into a collaboration agreement for the development and commercialization of Pfizer's investigational HGH therapy, PF-06939926, for the treatment of pediatric patients with growth hormone deficiency.
- In October 2021, Eli Lilly and Company received approval from the European Medicines Agency (EMA) for an updated indication of its HGH therapy, Humatrope, for the treatment of children with Prader-Willi syndrome.
Human Growth Hormone Key Market Trends
- Personalized Medicine Approaches: Physicians and researchers are increasingly focusing on tailoring HGH therapy based on individual patient characteristics, including genetic factors and specific medical conditions. In 2022, a clinical trial was initiated to explore the efficacy of personalized dosing regimens for HGH therapy in children with growth hormone deficiency. This trial aimed to evaluate the benefits of individualized treatment approaches in optimizing growth outcomes.
- Expansion of Therapeutic Applications: Researchers are investigating potential applications of HGH in fields such as regenerative medicine, hormone replacement therapy, and age-related disorders. In 2022, a research study demonstrated the potential of HGH therapy in promoting muscle regeneration and enhancing functional recovery in animal models of muscle injury. This finding opened up possibilities for utilizing HGH in regenerative medicine approaches for muscle-related conditions.
Human Growth Hormone Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global human growth hormone market analysis, the market for HGH is driven by several factors. One of the primary drivers is the increasing prevalence of growth hormone-related disorders such as growth hormone deficiency, Turner syndrome, and Prader-Willi syndrome. The growing awareness among healthcare professionals and patients about the benefits of HGH therapy has led to a surge in demand. The availability of favorable reimbursement scenarios in many countries has also contributed to market growth. The global HGH market is experiencing steady growth driven by increasing awareness, the prevalence of growth hormone-related disorders, and favorable reimbursement scenarios. While challenges exist, such as high costs and complex regulations, the market presents opportunities for innovation and expansion. With ongoing research, development of advanced therapies, and collaborations among key players, the HGH market is poised for further growth and advancement in addressing the needs of patients worldwide.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.5 billion |
| Market size value in 2031 | USD 16.03 billion |
| Growth Rate | 12.34% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Human Growth Hormone Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Human Growth Hormone Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Human Growth Hormone Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Human Growth Hormone Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Human Growth Hormone Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Human Growth Hormone Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
